Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
Category: Narcolepsy
-
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
The New York Times – Business:
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.